Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Harvard Business School
Chubb
AstraZeneca
McKinsey
Argus Health
Healthtrust
Farmers Insurance
Merck

Generated: November 17, 2018

DrugPatentWatch Database Preview

Eculizumab - Biologic Drug Details

« Back to Dashboard

Summary for eculizumab
Tradenames:1
Patents:59
Applicants:1
BLAs:1
Suppliers: see list1
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for eculizumab
Pharmacology for eculizumab
Mechanism of ActionComplement Inhibitors

US Patents for eculizumab

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Alexion Pharm SOLIRIS eculizumab INJECTABLE; IV (INFUSION) 125166 001 2007-03-16 ➤ Try a Free Trial Alexion Pharmaceuticals, Inc. (Cheshire, CT) ➤ Try a Free Trial RX Orphan company
Alexion Pharm SOLIRIS eculizumab INJECTABLE; IV (INFUSION) 125166 001 2007-03-16 ➤ Try a Free Trial Janssen Pharmaceutica NV (Beerse, BE) ➤ Try a Free Trial RX Orphan search
Alexion Pharm SOLIRIS eculizumab INJECTABLE; IV (INFUSION) 125166 001 2007-03-16 ➤ Try a Free Trial Aegis Therapeutics LLC (San Diego, CA) ➤ Try a Free Trial RX Orphan search
Alexion Pharm SOLIRIS eculizumab INJECTABLE; IV (INFUSION) 125166 001 2007-03-16 ➤ Try a Free Trial Teva Pharmaceuticals Industries, Ltd. (Petach-Tikva, IL) ➤ Try a Free Trial RX Orphan search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for eculizumab

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0758904/01 Switzerland ➤ Try a Free Trial FORMER REPRESENTATIVE: VOSSIUS AND PARTNER, CH
2010 00003 Denmark ➤ Try a Free Trial
C/GB10/015 United Kingdom ➤ Try a Free Trial PRODUCT NAME: ECULIZUMAB; REGISTERED: UK EU/1/07/393/001 20070620
C0016 France ➤ Try a Free Trial PRODUCT NAME: ECULIZUMAB; REGISTRATION NO/DATE: EU/1/07/393/001 20070620
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Fuji
Moodys
Teva
Johnson and Johnson
US Department of Justice
Cerilliant
Harvard Business School
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.